Impact of Rifaximin Therapy on Intestinal Byproducts in End-Stage Renal Disease
Clinical trial NCT02738905 · WITHDRAWN
Trial details
- NCT number
- NCT02738905
- Sponsor
- Jason Stubbs, MD
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2019-02-26
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.